MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling.
about
lncRNA/MicroRNA interactions in the vasculatureAdventitial vessel growth and progenitor cells activation in an ex vivo culture system mimicking human saphenous vein wall strain after coronary artery bypass graftingZIPK is critical for the motility and contractility of VSMCs through the regulation of nonmuscle myosin II isoforms.MicroRNA-365 inhibits vascular smooth muscle cell proliferation through targeting cyclin D1MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivoGenome-wide microRNA changes in human intracranial aneurysms.Biophysical induction of vascular smooth muscle cell podosomes.BRG1 overexpression in smooth muscle cells promotes the development of thoracic aortic dissection.Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.Alteration of mRNA and microRNA expression profiles in rat muscular type vasculature in early postnatal development.Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertensionThe roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation.Integrating molecular genetics and systems approaches to pulmonary vascular diseases.MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1Maturation and differentiation of the fetal vasculature.Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulationRestoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.Novel Targets of Drug Treatment for Pulmonary Hypertension.Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction.miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation.A novel system for studying mechanical strain waveform-dependent responses in vascular smooth muscle cells.HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia.Pentose Shunt, Glucose-6-Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension.MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1.Dicer generates a regulatory microRNA network in smooth muscle cells that limits neointima formation during vascular repair.MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation.Macrophage-derived extracellular vesicles mediates smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV-infection and substance abuse.MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling.miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.
P2860
Q26766577-7C20B4D0-E57E-4A96-9A86-2ED0E93174A1Q27316157-EF9B7A51-9B6A-48C2-91E6-20FBCA3AF3AEQ33568853-465658F1-575F-4FE0-813E-22BCE75ED79BQ33754673-7572D0CB-1851-4127-9F30-52AA46CC70BFQ33783904-E6911749-822A-45E2-973B-72088CE239DAQ34409808-B18318C0-4CF7-414E-8D38-0FB4FF40F71BQ35191576-A7263CBF-5DCA-4EBE-9FF9-9D6FFA9B51E8Q35321883-8FC1B92C-3C69-4D74-B41B-A4126826335DQ35649420-8742A365-A0CA-4EF2-8961-0DA0885A0147Q35739912-A76C3141-2539-432C-AE56-60220C8E623BQ35770214-20AC3B4E-463D-4A27-A852-4B6CEA087DB5Q35816374-4092C932-F864-4F17-8530-BD9CF0AB27AEQ35957299-83AE1D8D-FF92-40B7-B5DF-D760A3A5F9DEQ36810797-DE5523F7-8174-4687-B56B-BEA7EEB05AD0Q36943405-A39273E2-A1F1-43AC-82CC-AA1C1632F663Q37558503-51508C24-C656-4D7A-82DE-E3B827866203Q37562000-802AC53F-1C16-43C2-9065-0581D03870C7Q38206962-EB511896-E6C8-4F45-87A3-49948A65F7FBQ38504399-863B895A-D85E-47BE-83BF-EAA59A56CC2BQ40336889-A08A5DE9-81D4-4591-8661-8E44DD5E1EE2Q41592757-81513C36-FB57-4C67-A366-97BCC39BA99AQ41765546-BBA321CF-0A27-457C-9942-4BEE88AADA2AQ41865858-39C9B3E7-71CA-46B2-80DE-48ABC61E4139Q41890576-0D0ADEDD-63F0-4B52-A68A-3C174F4F3E3FQ46070238-30D4802B-37D2-4188-9C7B-E4B7357DE65EQ46280894-D7EF8D4D-2CFC-4CB5-8190-E0C1DF341349Q47104906-E1BF34B6-330A-48BC-B2FF-43C30E8F1AF6Q48358059-BF27FF2E-B0E9-4D7E-9A05-AB28943667F9Q48458943-0A5A488F-72FA-4A96-BE23-8132079E97A4Q52718334-47711A82-F7CB-4DE7-8D28-C0AA9ECFCFDDQ52766285-24FDC814-3FCA-43C4-A652-0B5EB0B78826Q55026266-8EDEBB21-4FC8-489B-A06B-8F47E392513F
P2860
MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
MicroRNA and vascular remodell ...... ulmonary vascular remodelling.
@en
MicroRNA and vascular remodell ...... ulmonary vascular remodelling.
@nl
type
label
MicroRNA and vascular remodell ...... ulmonary vascular remodelling.
@en
MicroRNA and vascular remodell ...... ulmonary vascular remodelling.
@nl
prefLabel
MicroRNA and vascular remodell ...... ulmonary vascular remodelling.
@en
MicroRNA and vascular remodell ...... ulmonary vascular remodelling.
@nl
P2093
P2860
P356
P1476
MicroRNA and vascular remodell ...... ulmonary vascular remodelling.
@en
P2093
Akiko Hata
Andrew H Baker
Margaret R MacLean
Robert A McDonald
P2860
P304
P356
10.1093/CVR/CVR299
P577
2011-11-07T00:00:00Z